Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Mycobacterium ulcerans

ABSTRACT: Causative agent of Buruli and Bairnsdale ulcer

PROVIDER: PRJNA15695 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	DRR016048_1.fastq.gz	Fastqsanger.gz
	DRR016048_2.fastq.gz	Fastqsanger.gz
	SRR1006174_consensus.fastq.gz	Fastqsanger.gz
	SRR1006175_consensus.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 867

Similar Datasets

Mycobacterium ulcerans Agy99

Project description:The causal agent of Buruli ulcer

| PRJNA16230 | ENA

RNA-seq strategy to study Mycobacterium ulcerans adaptation within our original mouse model of spontaneous healing.

Project description:Mycobacterium ulcerans is the causal agent of Buruli ulcer, a chronic infectious disease and the third most common mycobacterial disease worldwide. Without early treatment, M. ulcerans provokes massive skin ulcers, caused by the mycolactone toxin, its main virulence factor. However, spontaneous healing may occur in Buruli ulcer patients several months or years after the disease onset. We have shown, in an original mouse model, that bacterial load remains high and viable in spontaneously healed tissues, suggesting that M. ulcerans switches to low levels of mycolactone production, adapting its strategy to survive in such a hostile environment. We investigated the regulation of mycolactone production, by using an RNA-seq strategy to study bacterial adaptation within our original mouse model of spontaneous healing. Pathway analysis and characterization of the tissue environment showed that the bacillus adapted to its new environment by modifying its metabolic activity and switching nutrient sources. Thus, M. ulcerans ensures its survival in healing tissues by reducing its secondary metabolism, leading to an inhibition of mycolactone synthesis and changes in cell wall composition. These findings shed new light on mycolactone regulation and pave the way for new therapeutic strategies.

2021-05-17 | GSE157956 | GEO

Mycobacterium ulcerans

Project description:Comparative genomics reveals diversity and spatial clustering of Mycobacterium ulcerans in a small Buruli ulcer endemic area of West-Africa

| PRJNA499075 | ENA

Transcriptomics in whole-blood cells of Buruli ulcer patients identifies a signature of inflammation

Project description:Mycolactone, a lipid-like toxin, is the major virulence factor of Mycobacterium ulcerans, the etiological agent of Buruli ulcer. Its involvement in lesions development has been widely described in early stages of the disease, through its cytotoxic and immunosuppressive activities, but less is known about later stages. Here, we revisit the role of mycolactone in disease outcome and provide the first demonstration of the pro-inflammatory potential of this toxin. We found that the mycolactone-containing mycobacterial extracellular vesicles produced by M. ulcerans induced the production of IL-1β, a potent pro-inflammatory cytokine, in a TLR2-dependent manner, targeting NLRP3/1 inflammasomes. We showed our data to be relevant in a physiological context. The in vivo injection of these mycolactone-containing vesicles induced a strong local inflammatory response and tissue damages, which were prevented by corticosteroids. Finally, several soluble pro-inflammatory factors, including IL-1β, were detected in infected tissues from mice and Buruli ulcer patients. Our results revisit Buruli ulcer pathophysiology by giving a new insight, thus paving the way for development of new therapeutic strategies, taking account the pro-inflammatory potential of mycolactone.

2020-12-29 | GSE157350 | GEO

Central African Mycobacterium ulcerans population genomics

Project description:Mycobacterium ulcerans population genomics to inform on the spread of Buruli ulcer across central Africa

| PRJEB30333 | ENA

Project description:PPE barcoding the Buruli ulcer agent, Mycobacterium ulcerans

| PRJNA705996 | ENA

Mycobacterium tuberculosis

Project description:Causative agent of tuberculosis

| PRJNA12318 | ENA

Mycobacterium tuberculosis H37Rv

Project description:Causative agent of tuberculosis.

| PRJNA224 | ENA